Cassava Sciences Inc.

NASDAQ: SAVA · Real-Time Price · USD
2.35
-0.06 (-2.49%)
At close: Aug 15, 2025, 3:59 PM
2.33
-0.85%
After-hours: Aug 15, 2025, 07:46 PM EDT

Cassava Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
128.57M 121.14M 201.01M 233.44M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a 399K
Receivables
947K 962K n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
6.21M 6.78M 10.21M 10.38M
Total Current Assets
136.53M 129.63M 211.23M 244.48M
Property-Plant & Equipment
20.96M 21.85M 22.99M 20.83M
Goodwill & Intangibles
37K 176K 622K 1.07M
Total Long-Term Assets
21M 22.03M 23.61M 22.3M
Total Assets
157.53M 151.66M 234.83M 266.78M
Account Payables
7.65M 10.57M 4.02M 7.13M
Deferred Revenue
n/a n/a n/a 4.68M
Short-Term Debt
n/a n/a 104K 97K
Other Current Liabilities
2.74M 3.42M 2.67M 3.34M
Total Current Liabilities
11.75M 14.2M 7.06M 12.53M
Long-Term Debt
n/a n/a 35K 139K
Other Long-Term Liabilities
79K n/a 162K 55K
Total Long-Term Liabilities
79K n/a 232K 333K
Total Liabilities
11.83M 14.2M 7.29M 12.87M
Total Debt
n/a n/a 139K 236K
Common Stock
48K 42K 511.09M 461.22M
Retained Earnings
-405.11M -380.77M -283.55M -207.31M
Comprehensive Income
n/a n/a n/a 0.00
Shareholders Equity
145.7M 137.47M 227.54M 253.91M
Total Investments
n/a n/a n/a n/a